Stroke · 2007 · 123 citations · 22 references
MedicineNeurologyRadiologyBiomedical ImagingDiagnostic ImagingDiagnostic RadiologyAcute Ischemic StrokeCerebrovascular DiseaseIntracerebral HemorrhagePerfusion ImagingStrokeStroke ImagingHemorrhagic Transformation DetectionIntravenous Tissue Plasminogen ActivatorIschemic Stroke Diffusion ImagingIschemic Stroke Perfusion ImagingNeuroimaging Of Intracerebral HemorrhageNeuroimaging Of Ischemic StrokePerfusion-weighted ImagingThrombolysis Complications
BACKGROUND AND PURPOSE: Intracerebral hemorrhage represents the most feared complication of treatment with intravenous tissue plasminogen activator. We studied whether perfusion-weighted imaging and diffusion-weighted imaging has the potential to identify patients at risk of severe intracerebral hemorrhage after treatment with intravenous tissue plasminogen activator. METHODS: We analyzed data of prospectively studied MRI selected acute ischemic stroke patients treated with intravenous tissue plasminogen activator within 6 hours. All patients were examined by perfusion- and diffusion-weighted imaging < or =6 hours. Perfusion- and diffusion-weighted imaging lesion volumes were calculated. Hemorrhagic transformation was assessed on follow-up CT or MRI and diagnosed as hemorrhagic transformation, parenchymal hemorrhage, or symptomatic intracerebral hemorrhage according to ECASS II criteria. RESULTS: Of 152 patients, hemorrhagic transformation was seen in 60 (39.5%), parenchymal hemorrhage in 15 (9.9%), and symptomatic intracerebral hemorrhage in 4 (2.6%). Multiple logistic regression analysis identified onset to treatment time after 3 to 6 hours (P<0.001), a larger perfusion-weighted imaging lesion volume (P=0.002), and, as a tendency, a higher score on the National Institutes of Health Stroke Scale on admission (P=0.068) as independent predictors of hemorrhagic transformation. Neither MRI lesion volumes nor severity of symptoms, but rather only an older age tended to be associated with parenchymal hemorrhage (P=0.087). CONCLUSIONS: Our results further support the concept of a different pathogenesis for hemorrhagic transformation and parenchymal hemorrhage. Whereas hemorrhagic transformation should be regarded as a clinically irrelevant epiphenomenon of ischemic damage and reperfusion, parenchymal hemorrhage appears to be related to biologic effects of tissue plasminogen activator and other pre-existing pathologic conditions, which deserve further investigation.
22
Interobserver agreement for the assessment of handicap in stroke patients.
John C. van Swieten, Peter J. Koudstaal, Marieke C. Visser et al. · Stroke · 1988 · 6.5K citations · Full text
Life Sciences, Neurology, Functional Movement Assessment +14
Measurements of acute cerebral infarction: a clinical examination scale.
Thomas Brott, Harold P. Adams, Charles P. Olinger et al. · Stroke · 1989 · 5.8K citations
Intra-arterial Prourokinase for Acute Ischemic Stroke
Paul T. Akins · JAMA · 2000 · 792 citations
Medicine, Neurology, Pharmacotherapy +17